GIC:NYSEGlobal Industrial Company Analysis
Data as of 2026-06-14 - not real-time
$31.84
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Global Industrial (GIC) is trading at $31.84, just above its 20‑day SMA of $30.27 and its 50‑day SMA of $31.41, with the price hovering near the calculated resistance of $32.49. The RSI of 62.8 and a bullish MACD histogram suggest lingering momentum, yet volume has been trending lower and 30‑day volatility is high at 35.7%, underscoring short‑term uncertainty. The recent Q1 2026 earnings beat estimates but prompted a 10% share decline as analysts flagged concerns over long‑term growth and profitability, a reaction reflected in the “bearish” trend label despite the technical bullish signals.
Fundamentally, GIC delivers solid growth with 9.2% revenue expansion, a 24% ROE, and a healthy free cash flow of $61M, while its forward PE of 14.4 and a trailing PE of 16.8 are well below the industry average of 30.6, indicating relative value. The dividend yield of 3.39% and a 56% payout ratio appear sustainable given the cash flow profile, and the DCF fair value of $30.18 suggests the current price is modestly premium to intrinsic value but still offers upside to the analyst median target of $40. These dynamics point to a mixed technical outlook but a fundamentally sound, value‑oriented investment case.
Fundamentally, GIC delivers solid growth with 9.2% revenue expansion, a 24% ROE, and a healthy free cash flow of $61M, while its forward PE of 14.4 and a trailing PE of 16.8 are well below the industry average of 30.6, indicating relative value. The dividend yield of 3.39% and a 56% payout ratio appear sustainable given the cash flow profile, and the DCF fair value of $30.18 suggests the current price is modestly premium to intrinsic value but still offers upside to the analyst median target of $40. These dynamics point to a mixed technical outlook but a fundamentally sound, value‑oriented investment case.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price near resistance with decreasing volume
- High short‑term volatility (35% 30‑day)
- Recent earnings beat but market concerns on growth
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Attractive valuation vs industry PE
- Strong revenue growth and high ROE
- Sustainable dividend yield above 3%
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Consistent cash flow generation
- Low beta indicating defensive characteristics
- Long‑term upside to $40 target price
Key Metrics & Analysis
Financial Health
Revenue Growth9.20%
Profit Margin5.33%
P/E Ratio16.8
ROE24.28%
ROA11.18%
Debt/Equity31.01
P/B Ratio3.8
Op. Cash Flow$80.8M
Free Cash Flow$61.0M
Industry P/E30.6
Technical Analysis
TrendBearish
RSI62.8
Support$28.00
Resistance$32.49
MA 20$30.27
MA 50$31.41
MA 200$31.81
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Fair Value$30.18
Target Price$40.00
Upside/Downside25.63%
GradeFair
TypeBlend
Dividend Yield3.39%
Risk Assessment
Beta0.62
Volatility35.65%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
ZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKWENN
Wen Acquisition Corp
STOCKCOIN
Coinbase Global, Inc.
STOCKTTRX
Turn Therapeutics Inc.
STOCKQNTM
Quantum Biopharma Ltd.
STOCKPSFE
Paysafe Limited
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.